4Ludescher C, Pall G, Irschick EU, et al. Differential activity of Pglycoprotein in normal blood lymphocyte subsets[J ]. Br J Haematol, 1998,101(4) :722-727.
5Yamashiro T, Watanabe N, Yokoyama KK, et al. Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity [ J ]. Biochem Pharmocol, 1998, 55(9) : 1385-1390.
6Takahashi M, Misawa Y, Watanabe N, et al. Role of P-glycoprotein in human natural killer-like cell line-mediated cytotoxicity[J].Exp Cell Res, 1999,253(2) : 369-402.
7Ncho M, hobbs JA, Brahmi Z. Over-expression of multidrug resistance P-glycoprotein inhibits NK granule-mediated lyric ability without affecting the Fas lytic pathway[J]. Hum Immunol, 1999,60(3) :223-230.
8Azuma E, Masuda S, Qi J, et al. Cytotoxic T-lymphoeytes recognizine P-glycoprotein in murine multidrug-resistant leukemias [ J ].Eur J Haematol, 1997,59(1) : 14-19.
9Zehrer C, Beck J, Geketer V, et al. Superantigen-mediated cellular cytotoxicity is dependant on antigen expression, but independent of the P-g[ycoprotein multidrug resistance phenotype[J]. Br J Haema tol,1996, 95(3):452-456.
10Johnstone RW, Tainton KM, Ruefli AA, et al. P-glycoprotein dose not protect cells against cytolysis induced by pore-forming proteins[J]. J Biol Chem,2001, 276(20) : 16667-16673.
